| Application no. and date | 99916921.2 (espacenet) (Federated) (European Patent Register), 19990415 | | Patent/reg. no. and date | DK/EP 1073417, 20021204 | | Publication date | 20010207 | | Priority no. and date | GB 9808152, 19980418, GB 9814709, 19980708 | | EP pub. no. and date |
EP 1073417 20010207 | | Effective date | | | Applicant/owner | GLAXO GROUP LIMITED, Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB6 ONN, GB | | Applicant ref. no. | 107627 | | Inventor | CAVAILLON, P.,
Lab. Glaxo Wellcome,
Zone Ind. no2, 23, rue Lavoisier
Boîte postale3531
27035 Evreux Cedex, FR,
LLORCA, N.,
Lab. Glaxo Wellcome,
Zone Ind. no2, 23, rue Lavoisier
Boîte postale 3531
27035 Evreux Cedex, FR,
LOUIS, O.,
Lab. Glaxo Wellcome,
Zone Ind. No 2, 23, rue Lavoisier
Boîte postale 3531
27035 Evreux Cedex, FR,
ROSIER, P.,
Lab. Glaxo Wellcome,
Zone Ind. no. 2, 23, rue Lavoisier,
Boîte postale 3531
27035 Evreux Cedex, FR | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/57, A61K 9/16, A61K 9/12 | | Title | Farmaceutisk aerosolformulering | | Int. application no. | PCT/EP99/02535 | | Int. publication no. | WO99053901 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
